IL1B and Alzheimer disease: The injection also inhibited the overactivation of microglia and astrocytes within the hippocampus of AD mice, while decreasing the expression of IL-1β, IL-6, TNF-α, and amyloid-β (Aβ)1-42, and increasing the expression of synapse-associated proteins and BDNF [72].